ADA Scientific Sessions (14,000 attendees, managed by A. Fassano) is the anchor show for diabetes devices, glucose monitors, insulin pumps, and CGM systems. ENDO (Endocrine Society, 7,000 attendees, also managed by A. Fassano) covers the broader endocrinology spectrum including thyroid, adrenal, and metabolic disorders. ObesityWeek (3,500 attendees) is the dedicated obesity medicine show. If you sell diabetes technology, ADA is mandatory. The Fassano relationship across both ADA and ENDO creates leveraging opportunities for companies that exhibit at both. ObesityWeek is growing rapidly as GLP-1 and surgical weight management gain traction.
Every figure on this page is an estimate read from the organizer's own published
exhibitor prospectus, linked below. They are estimates, not quotes, so confirm
current pricing with the organizer before committing a budget.
The other 3conferences on
this page publish no booth pricing we can link
to, so they show "Cost not published" rather than
an estimate.
